(Q47887117)

English

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus.

scientific article published in October 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

insulin therapy

1 reference

based on heuristic

inferred from title

Carlo L Acerini

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

David B. Dunger

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

Martin O. Savage

3

object named as

M O Savage

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

author name string

C M Patton

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

A Kernell

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

O Westphal

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

350

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

1199-1204

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

9086

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Total glycosylated haemoglobin (HbA1) levels in diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of diabetic retinopathy in children and adolescents with IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased Overnight Growth Hormone Concentrations in Diabetic Compared with Normal Adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin and insulin-like growth factors in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion in IDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effects of Repeated Daily Recombinant Human Insulin-like Growth Factor I Administration in Adolescents with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Capillary blood on filter paper for determination of HbA1c by ion exchange chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

THE GROWTH HORMONE INDEPENDENT INSULIN-LIKE GROWTH FACTOR-I BINDING PROTEIN BP-28 IS ASSOCIATED WITH SERUM INSULIN-LIKE GROWTH FACTOR-I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN-DEPENDENT DIABETICS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse events and their association with treatment regimens in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factors. Studies in diabetics with and without retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of growth hormone in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2906467-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)06467-2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652560

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47887117&oldid=2063496526"